Country: Malta
Language: English
Source: Medicines Authority
BUDESONIDE
Teva Pharma B.V. Swensweg 5, 2031 GA Haarlem, Netherlands
R03BA02
BUDESONIDE 1 mg
NEBULISER SUSPENSION
BUDESONIDE 1 mg
POM
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Withdrawn
2013-10-31
1 PACKAGE LEAFLET: INFORMATION FOR THE USER BUDESONIDE TEVA PHARMA 0.25 MG/2 ML NEBULISER SUSPENSION BUDESONIDE TEVA PHARMA 0.5 MG/2 ML NEBULISER SUSPENSION BUDESONIDE TEVA PHARMA 1 MG/2 ML NEBULISER SUSPENSION BUDESONIDE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. WHAT BUDESONIDE TEVA PHARMA NEBULISER SUSPENSION IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU USE BUDESONIDE TEVA PHARMA NEBULISER SUSPENSION 3. HOW TO USE BUDESONIDE TEVA PHARMA NEBULISER SUSPENSION 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE BUDESONIDE TEVA PHARMA NEBULISER SUSPENSION 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT BUDESONIDE TEVA PHARMA NEBULISER SUSPENSION IS AND WHAT IT IS USED FOR Budesonide belongs to a group of steroids called glucocorticosteroids which can be used to reduce or prevent inflammatory reactions (swelling) in the lungs. This medicine can be used in adults, adolescents, children and infants aged 6 months and older. Your medicine is used for the treatment of asthma. It is used in patients where other types of inhaler, such as a pressurised inhaler or an inhaler containing a dry powder are unsatisfactory or inappropriate. Budesonide Nebuliser suspension can also be used to treat very serious pseudocroup (laryngitis subglottica) in infants and children who are in hospital. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE BUDESONIDE TEVA PHARMA NEBULISER SUSPENSION DO NOT USE BUDESONIDE TEVA PHARMA NEBULISER SUSPENSION - if you are allergic to budesonide or any of the other ingredients of thi Read the complete document
Page 1 of 14 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Budesonide Teva Pharma 0.25 mg/2 ml Nebuliser Suspension Budesonide Teva Pharma 0.5 mg/2 ml Nebuliser Suspension Budesonide Teva Pharma 1 mg/2 ml Nebuliser Suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Budesonide Teva Pharma 0.25 mg/2ml Nebuliser Suspension: One ampoule of 2 ml suspension contains 0.25 mg budesonide. Budesonide Teva Pharma 0.5 mg/2 ml Nebuliser Suspension: One ampoule of 2 ml suspension contains 0.5 mg budesonide. Budesonide Teva Pharma 1 mg/2 ml Nebuliser Suspension: One ampoule of 2 ml suspension contains 1 mg budesonide. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Nebuliser suspension. A white to off white suspension in a single dose ampoule. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Budesonide Nebuliser Suspension is indicated in adults, adolescents, children and infants aged six months and older. _Asthma _ Budesonide Nebuliser Suspension is indicated for the use in persistent bronchial asthma, in patients where use of a pressurised inhaler or dry powder formulation is unsatisfactory or inappropriate. _Pseudocroup _ Very serious pseudocroup (laryngitis subglottica), in which hospitalisation is indicated. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For inhalation use. Page 2 of 14 Posology _Asthma _ The dose should be given twice daily. Administration once daily may be considered in cases of mild to moderate stable asthma. INITIAL DOSAGE: The initial dose should be tailored to the severity of the disease and thereafter should be adjusted on an individual basis. The following doses are recommended but the minimum effective dose should always be sought. Children aged 6 months and above: 0.25 – 1.0 mg daily. For patients in maintenance therapy with oral steroids a higher initial dosage up to 2.0 mg daily should be considered. Adults (including older people) and children/adolescents over 12 years of age: 0.5 – 2.0 mg daily. In very severe cases the dosage may be increa Read the complete document